Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk

J Exp Clin Cancer Res. 2023 Jul 18;42(1):173. doi: 10.1186/s13046-023-02741-x.

Abstract

Cancer is the main cause of death worldwide and metastasis is a major cause of poor prognosis and cancer-associated mortality. Metastatic conversion of cancer cells is a multiplex process, including EMT through cytoskeleton remodeling and interaction with TME. Tens of thousands of putative lncRNAs have been identified, but the biological functions of most are still to be identified. However, lncRNAs have already emerged as key regulators of gene expression at transcriptional and post-transcriptional level to control gene expression in a spatio-temporal fashion. LncRNA-dependent mechanisms can control cell fates during development and their perturbed expression is associated with the onset and progression of many diseases including cancer. LncRNAs have been involved in each step of cancer cells metastasis through different modes of action. The investigation of lncRNAs different roles in cancer metastasis could possibly lead to the identification of new biomarkers and innovative cancer therapeutic options.

Keywords: Cancer metastasis; Cytoskeleton remodeling; EMT; Functional screening; Long non-coding RNAs; RNA-based therapeutics.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Cell Movement / genetics
  • Cytoskeleton / metabolism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasm Metastasis / pathology
  • Neoplasms* / pathology
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism

Substances

  • RNA, Long Noncoding
  • Biomarkers